Price target
17.500.000.00%
The 6 analysts offering 1 year price forecasts for PCJ have a max estimate of — and a min estimate of —.
Analyst rating
Based on 6 analysts giving stock ratings to PCJ in the past 3 months.
EPS
Reported
Estimate
Reported
Estimate
Surprise
Revenue
Reported
Estimate
Reported
Estimate
Surprise
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
PCJ EPS for the last quarter is 0.45 CHF despite the estimation of −0.32 CHF. In the next quarter EPS is expected to reach −0.32 CHF. Track more of ABEONA THERAPEUTIC financials and stay on top of what is up with the company.
In the next quarter ABEONA THERAPEUTIC revenue is expected to reach 0.00 CHF. Check out ABEONA THERAPEUTIC revenue and earnings and make informed decisions.
According to analysts, PCJ price target is 17.50 CHF with a max estimate of 20.67 CHF and a min estimate of 14.05 CHF. Check if this forecast comes true in a year, meanwhile watch ABEONA THERAPEUTIC stock price chart and keep track of the current situation with PCJ news and stock market news.
We've gathered opinions of 6 analysts rating PCJ stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as strong buy. Note that it's not a trading advice — your own analysis is still required.